TISHA KLINGENBERG: Open Payments
NPI 1326744806 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 56 payments from 17 companies in 2025. Trend: 2023 $1,319 · 2024 $2,072 · 2025 $1,541
Food & beverage: $1,541
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $402 |
| AstraZeneca Pharmaceuticals LP | 9 | $298 |
| Amgen Inc. | 7 | $224 |
| Novo Nordisk Inc | 8 | $200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Viatris Specialty LLC | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Chiesi USA, Inc. | 1 | $27 |
Products named: JARDIANCE, FARXIGA, Ozempic, Repatha, ZEPBOUND, AIRSUPRA, MOUNJARO, OTEZLA.
Industry payments across CA — which companies pay providers there.
